Exercise of Share Options & Holding in the Company

SulNOx Group PLC
29 June 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

 29 June 2023

 

SulNOx Group Plc (the "Company" or "SulNOx")

 

Exercise of Share Options

Holding in the Company

 

(Aquis Stock Exchange: SNOX)

 

The board of directors of the Company (the "Board") is pleased to announce that Tergeo Limited, a company controlled by Constantine Logothetis, has exercised the options notified earlier today to subscribe for 3,765,300 new ordinary shares of 2 pence each ("Ordinary Shares") at a price of 10 pence per share (the "New Shares"), raising £376,530. It is expected that the proceeds will be utilised for general working capital purposes.

 

Following the issue of the New Shares, including Ordinary Shares already held by Tergeo Limited, Mr Logothetis will have an interest in a total of 17,569,854 Ordinary Shares, equivalent to 16.31% of the Ordinary Shares, as enlarged by the New Shares.

 

The New Shares to be allotted will utilise SulNOx's existing unspent share issue authorities and are expected to be admitted to trading on the AQSE Growth Market on 6 July 2023 ("Admission").  On Admission, the Company will have 107,711,393 Ordinary Shares in issue, each with one voting right. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company is 107,711,393. This figure should be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

- Ends -

 

For further information please contact:

 

SulNOx Group plc
Steven Cowin, CFO

 

Tel: 07624 491 821



Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

Tel: 020 3328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100